Semaglutide Side Effects: Ozempic vs Wegovy vs Compounded

Semaglutide side effects are mostly digestive: nausea, diarrhea, vomiting, constipation, and abdominal pain. Serious problems stay uncommon. What changes the picture is your dose. In the FDA trials behind Wegovy, 44% of adults reported nausea at 2.4 mg weekly. On Ozempic 1 mg, that figure was 20.3%.

That gap is the point of this page. Our broader GLP-1 side effects overview covers the drug class. Here we stay on one molecule and look at how the product in your fridge changes what you feel.

What Are the Most Common Semaglutide Side Effects?

Semaglutide slows how fast your stomach empties. It also quiets appetite signals in the brain. Those two actions explain almost every complaint we hear in the first three months at Foundation Wellness. The common side effects follow from that pair, and most of them are symptoms of a gut running slower than it used to.

The table below comes from the FDA prescribing information for Wegovy, pooled across three placebo-controlled trials in 2,116 adults.

Read the placebo column before you worry. Sixteen percent of adults on a dummy injection reported nausea as well. Ordinary life produces a surprising amount of stomach trouble.

The gap is still real, though. Vomiting ran four times as common on the drug. Eructation, which is the clinical word for burping, showed up in 7% of the treated group against under 1% on placebo.

Most patients ride it out. In those clinical trials, 6.8% of adults stopped because of adverse effects, against 3.2% on placebo. Nausea drove 1.8% of the exits and vomiting drove 1.2%.

Does the Dose Change What You Feel?

More than the brand name does. Semaglutide is one molecule sold under several labels, and each label uses a different dose range for a different job.

Two things in that table deserve a second look. The same 2.4 mg dose reported 44% nausea in one trial pool and 35% in another, which tells you how much trial design and patient mix affect these numbers. And the jump from 2.4 mg to 7.2 mg is smaller than most people expect.

One reaction breaks that pattern. Dysesthesia, an odd burning or tingling sensation in the skin, was reported by 22% of the 7.2 mg group against 6% at 2.4 mg. That’s a real dose signal, and it surprised us when the higher dose data came out.

The Ozempic injection for type 2 diabetes tops out lower, at 2 mg once weekly. Both sets of clinical trials studied the same molecule, so the difference you feel comes from milligrams rather than marketing. Gastrointestinal reactions overall ran 32.7% on 0.5 mg and 36.4% on 1 mg, against 15.3% on placebo.

Why Does Every Dose Increase Bring the Nausea Back?

Because your gut adapts to a level, then meets a new one. The escalation ladder exists to keep each step small enough to tolerate.

The Wegovy injection ladder runs like this:

• Weeks 1 through 4: 0.25 mg once weekly.
• Weeks 5 through 8: 0.5 mg.
• Weeks 9 through 12: 1 mg.
• Weeks 13 through 16: 1.7 mg.
• Week 17 onward: 1.7 mg or 2.4 mg as maintenance.

Each rung sits four weeks apart for a reason. The FDA label states plainly that the schedule is there to reduce the risk of gastrointestinal adverse reactions. Every step up is a bet that a smaller jump produces a smaller gastrointestinal side effect.

Week one rarely bothers anyone. The first real test arrives a day or two after your first step up, when nausea peaks and then fades. Think of it as a wave rather than a wall.

If a step knocks you flat, we hold you there. The label allows a provider to delay escalation by four weeks, and our team uses that option more often than we advance on schedule. Pushing through a miserable week is what makes patients quit treatment entirely.

Honestly, the most frustrating part of this job is watching someone abandon a plan that would have worked at a slower pace.

How Do Ozempic, Wegovy, and the Oral Tablet Differ?

Same active drug, different rules. Those rules matter more than most patients realize, and mixing them up causes avoidable misery.

Missed dose handling splits the two injections. With Ozempic, you take a missed dose within five days, then return to your usual day. With the Wegovy injection, you take it if the next scheduled dose is more than two days away, and skip it otherwise. Miss two Wegovy doses in a row and your provider restarts escalation at a lower rung.

Oral semaglutide adds another layer. Rybelsus and the newer Wegovy tablet have to be swallowed whole on an empty stomach, with no more than four ounces of water, followed by a 30 minute wait before food, drink, or other oral medication.

That waiting rule isn’t fussiness. Absorption drops sharply without it, and patients who take the tablet with breakfast often report both weak results and stomach upset.

The Wegovy tablet escalates monthly rather than weekly: 1.5 mg for 30 days, then 4 mg, then 9 mg, then 25 mg for maintenance. In its trial, 6.9% of patients stopped for adverse effects against 5.9% on placebo, and the common side effects looked similar to the injection.

Is the Semaglutide Profile Different From Tirzepatide?

Somewhat, and the honest answer comes with a caveat. Cross-trial comparison is not a fair test, because the studies enrolled different people under different rules. Both product labels say so directly.

Notice the last row. Roughly the same share of patients quit each drug, even though the individual reaction rates look different. That’s the number we watch most closely, because it captures tolerability in a way single symptoms do not.

Mechanism explains part of the difference. Semaglutide acts on one receptor. Tirzepatide acts on two, adding GIP activity, which some researchers think blunts nausea. For a fuller breakdown, see our semaglutide vs tirzepatide comparison.

Can Semaglutide Cause Low Blood Sugar?

On its own, rarely. Semaglutide prompts insulin release mainly when blood sugar is already high, so it doesn’t drive your blood sugar level down the way injected insulin can.

Combination changes that. In glycemic control trials, low blood sugar risk climbed when semaglutide was used alongside insulin or an insulin secretagogue such as glipizide. Severe hypoglycemia occurred in 0.8% and 1.2% of patients taking Ozempic 0.5 mg and 1 mg with a sulfonylurea.

Documented symptomatic low blood sugar reached 29.8% on Ozempic 1 mg added to basal insulin, against 15.2% on placebo. Those are not small numbers.

Learn the warning signs before your first semaglutide injection:

• Shakiness, sweating, or a racing pulse.
• Sudden hunger or lightheadedness.
• Blurred vision or trouble focusing.
• Irritability arriving out of nowhere.

Treat symptoms early with 15 grams of fast carbohydrate, then recheck in 15 minutes. Glucose tablets in the glove box are a small habit worth building. Check your blood sugar more often in the days right after each step up, especially on insulin.

If you live with type 2 diabetes, we coordinate with whoever manages your diabetes medication before you start. The label tells providers to monitor blood glucose before and during treatment, and to consider reducing insulin or the secretagogue dose. Plenty of patients with type 2 diabetes end up cutting their other diabetes medication as blood sugar steadies.

Without type 2 diabetes, low blood sugar stays uncommon on semaglutide. Skipping meals because appetite vanished is still worth avoiding.

Which Semaglutide Reactions Warrant Stopping the Drug?

Uncommon, but each one carries symptoms worth memorizing. The FDA lists these in the warnings it applies to GLP-1 receptor agonists as a class.

• Acute pancreatitis. Belly pain that stays severe, sometimes radiating to the back, with or without vomiting. Stop the drug and seek medical attention.
• Gallbladder disease. Cholelithiasis was reported in 1.5% of patients on Ozempic 0.5 mg. Watch for upper right stomach pain, fever, or yellowing skin.
• Kidney injury from dehydration. Several days of vomiting or diarrhea can strain the kidneys badly enough to require dialysis in rare postmarketing reports.
• Allergic reaction. Anaphylaxis and angioedema have been reported. Any allergic reaction involving facial or throat swelling is an emergency.
• Pulmonary aspiration under anesthesia. Food can still sit in a slowed stomach. Tell your surgeon, anesthesiologist, and dentist that you take semaglutide.

Symptoms on that list earn a same day call rather than a wait and see week.

Diabetic retinopathy deserves its own paragraph. In a two-year trial of semaglutide in adults with type 2 diabetes and high cardiovascular risk, diabetic retinopathy complications occurred in 3% of the treated group against 1.8% on placebo. Among those with existing diabetic retinopathy the rates were 8.2% and 5.2%. Among those without a known history, 0.7% and 0.4%.

Rapid improvement in glucose control is a recognized trigger for these changes. So if you have type 2 diabetes and any eye disease, book a dilated exam before your first dose and keep your eye health appointments through the ramp.

Heart health gets watched as well. Ozempic 0.5 mg and 1 mg raised resting heart rate by 2 to 3 beats per minute in the placebo-controlled pool, which is why we check your pulse at every visit. The same class has also shown benefit against cardiovascular disease outcomes.

The boxed warning covers thyroid C-cell tumors seen in rodent studies. Semaglutide is contraindicated with a personal or family history of medullary thyroid carcinoma, or with MEN 2 syndrome.

Does Compounded Semaglutide Carry Extra Risk?

It carries a different one, and the reason is unglamorous: measurement. Compounded semaglutide usually arrives in a vial, and you draw each dose yourself.

The FDA has received multiple adverse event reports, some requiring hospitalization, tied to dosing errors with compounded injectable semaglutide. Patients measured incorrect doses. In some reports, clinicians miscalculated them.

The agency also flagged prescriptions written beyond approved label doses: more product per injection, doses taken too often, or titration moved too fast. Reported symptoms included nausea, vomiting, diarrhea, abdominal pain, and constipation.

Two further concerns are worth knowing. Some compounded products use salt forms such as semaglutide sodium, which the FDA says are different active ingredients. And compounded medications skip FDA review for safety, quality, and potency before they reach you.

None of that makes every compounded medication unsafe. It makes supervision the deciding factor. If you use a vial, you want a provider who supplies the right syringe size, writes the dose in units, and watches you draw it at least once.

Compounding pharmacies serve a genuine purpose when an approved product cannot meet a patient need. Our team walks through that tradeoff rather than pretending it doesn’t exist.

What Actually Helps During the Rough Weeks?

Small habits carry most of the load. Common side effects respond to routine far more often than to another medication. Here’s what our patients in American Fork report working during the first two months.

Timing helps too. Some patients move their weekly injection to Friday so the quietest stomach days land on the weekend. Others prefer the reverse. Keeping the same day each week is what makes the pattern readable.

Cold or room temperature food often sits better than hot food, mostly because it carries less smell. Crackers, yogurt, and clear broth are the standbys we hear about again and again.

Protein deserves its own line. Appetite drops fast on semaglutide, and drifting down to 40 grams a day without noticing is easy. That’s where fatigue and lost muscle usually begin.

Hair loss is a potential side effect worth naming here, since it reached 3% on Wegovy against 1% on placebo. It tracks with fast weight loss more than with the medication itself, and it tends to recover once your weight settles. Constipation is the common side effect patients ignore longest, and it is the one that spoils an otherwise smooth month.

Keep a short note on your phone for the first eight weeks. Write down the date you injected, the dose you were on, and anything you felt over the next two days. Ask about sleep health at the same visit, since appetite, mood, and rest tend to shift together during a big weight change.

What Happens to Side Effects If You Pause?

They fade, and then they can return. Semaglutide has a half-life of about a week, so the drug clears your system slowly. Nausea and constipation usually settle within two or three weeks of the last semaglutide injection. Symptoms that outlast a month off the drug usually point somewhere else.

Restarting is where patients get caught out. Miss two or more consecutive Wegovy injections and the label tells your provider to reinitiate escalation at a lower dosage. Your gut gave up some tolerance while you were off.

We see this after a vacation or a pharmacy delay. One patient returned from three weeks away, resumed 2.4 mg on her own, and spent four days unable to keep food down. Dropping back a rung would have cost her almost nothing.

Pausing for a week during a stomach bug counts as a routine adjustment rather than a failure. Tell your clinic, though. The restart plan should match how long you were actually off the medication.

Who Should Not Start Semaglutide at All?

Some people should skip this drug, and a careful screening visit catches that in about twenty minutes.

• Personal or family history of medullary thyroid carcinoma, or MEN 2 syndrome.
• A prior serious allergic reaction to semaglutide or any excipient in the product.
• Severe gastroparesis or another condition that already delays stomach emptying.
• Pregnancy, or plans to conceive in the coming months.

Pregnancy carries a specific rule. Because semaglutide has a long half-life, the label directs patients to stop it at least two months before a planned pregnancy, and Novo Nordisk runs a pregnancy exposure registry for anyone who conceives during treatment.

A history of pancreatitis, gallstones, or kidney disease doesn’t rule you out by itself. It changes how closely we watch and how slowly we move. Tell us about all your health conditions, including the ones you assume are unrelated.

When Should You Seek Medical Attention?

Call when symptoms cross from annoying into alarming. That list includes severe abdominal pain that won’t let up, vomiting you can’t stay ahead of, dark urine with dizziness, swelling of the face or throat, or low blood sugar you can’t correct with food.

Dehydration is the risk patients underestimate most. Two days of vomiting empties your tank faster than expected, and the symptoms are easy to wave off: dark urine, a dry mouth, dizziness on standing.

When you call, have four things ready:

• Your current dose and the date of your last injection.
• The symptoms, and the day each one started.
• Any other medication you took in the past week.
• Your most recent blood sugar reading, if you check it.

Speak up about the smaller stuff as well. Ongoing nausea, stubborn constipation, or fatigue that flattens your week are all fixable, and few of them require urgent medical attention. Adjusting the plan beats quitting on your own.

According to the National Institute of Diabetes and Digestive and Kidney Diseases, weight management medication works best alongside steady changes in eating and activity. That’s the part no injection does for you.

How We Run the Ramp at Foundation Wellness

Every plan starts with a screening visit in American Fork or by telehealth across Utah. We review your history, your other medication, and what you have already tried.

From there the ramp is deliberately unhurried. Our team would rather spend an extra month at 1 mg than lose a patient to a week they would rather not repeat. Thankfully, most people who hold a dose once do not need to hold it again.

Between visits, our team would rather hear about symptoms early than late. One message about week three nausea usually ends in a dose hold. Silence usually ends in a stopped medication and a lost year.

Bring your full medication list, supplements included. You can see how the monitored program runs on our GLP-1 injections in Utah page. Pricing sits on the GLP-1 cost in Utah page. For results rather than reactions, read how much weight you can lose on a GLP-1. Everything above is general information rather than medical advice for your situation, so bring your questions to a clinician who knows your chart.

Key Takeaways

• Common semaglutide side effects are digestive: 44% nausea, 30% diarrhea, and 24% each for vomiting and constipation at Wegovy 2.4 mg.
• Dose drives severity more than brand. Ozempic 1 mg reported 20.3% nausea against 44% for Wegovy 2.4 mg.
• Wegovy 7.2 mg added little nausea over 2.4 mg, but dysesthesia rose from 6% to 22%.
• Missed dose rules differ by product: five days for Ozempic, a two day window for the Wegovy injection.
• Oral semaglutide needs an empty stomach, four ounces of water, and a 30 minute wait before anything else.
• Low blood sugar is uncommon on semaglutide alone and much more likely alongside insulin or a sulfonylurea for type 2 diabetes.
• Anyone with type 2 diabetes and eye disease should have a dilated exam before the first dose.
• Compounded vials add a dosing error risk that supervision and the correct syringe largely solve.
• Foundation Wellness treats patients across American Fork, Provo, and the rest of Utah County.

Sources

• U.S. Food and Drug Administration, Wegovy (semaglutide) prescribing information, sections 2, 4, 5, 6 and 8 - dailymed.nlm.nih.gov.
• U.S. Food and Drug Administration, Ozempic (semaglutide) approved label, sections 2, 5 and 6 - dailymed.nlm.nih.gov.
• U.S. Food and Drug Administration, Zepbound (tirzepatide) approved label, section 6 - dailymed.nlm.nih.gov.
• U.S. Food and Drug Administration, medications containing semaglutide marketed for type 2 diabetes or weight loss - fda.gov.
• National Institute of Diabetes and Digestive and Kidney Diseases, prescription medications to treat overweight and obesity - niddk.nih.gov.
• Semaglutide, StatPearls, National Center for Biotechnology Information - ncbi.nlm.nih.gov.